Treatment of chronic low back pain - new approaches on the horizon
- PMID: 28546769
- PMCID: PMC5436786
- DOI: 10.2147/JPR.S132769
Treatment of chronic low back pain - new approaches on the horizon
Abstract
Back pain is the second leading cause of disability among American adults and is currently treated either with conservative therapy or interventional pain procedures. However, the question that remains is whether we, as physicians, have adequate therapeutic options to offer to the patients who suffer from chronic low back pain but fail both conservative therapy and interventional pain procedures before they consider surgical options such as discectomy, disc arthroplasty, or spinal fusion. The purpose of this article is to review the potential novel therapies that are on the horizon for the treatment of chronic low back pain. We discuss medications that are currently in use through different phases of clinical trials (I-III) for the treatment of low back pain. In this review, we discuss revisiting the concept of chemonucleolysis using chymopapain, as the first drug in an intradiscal injection to reduce herniated disc size, and newer intradiscal therapies, including collagenase, chondroitinase, matrix metalloproteinases, and ethanol gel. We also review an intravenous glial cell-derived neurotrophic growth factor called artemin, which may repair sensory nerves compressed by herniated discs. Another new drug in development for low back pain without radiculopathy is a subcutaneous monoclonal antibody acting as nerve growth factor called tanezumab. Finally, we discuss how platelet-rich plasma and stem cells are being studied for the treatment of low back pain. We believe that with these new therapeutic options, we can bridge the current gap between conservative/interventional procedures and surgeries in patients with chronic back pain.
Keywords: PRP; artemin; chemonucleolysis; chronic low back pain; clinical trials; new therapy; stem cells; tanezumab.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures




Similar articles
-
An Analysis of New Approaches and Drug Formulations for Treatment of Chronic Low Back Pain.Anesthesiol Clin. 2017 Jun;35(2):341-350. doi: 10.1016/j.anclin.2017.01.023. Epub 2017 Mar 14. Anesthesiol Clin. 2017. PMID: 28526154 Review.
-
[Relevance of nerve blocks in treating and diagnosing low back pain--is the quality decisive?].Schmerz. 2001 Dec;15(6):474-83. doi: 10.1007/s004820100035. Schmerz. 2001. PMID: 11793154 German.
-
Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.Acta Orthop Suppl. 2013 Feb;84(349):1-35. doi: 10.3109/17453674.2012.753565. Acta Orthop Suppl. 2013. PMID: 23427903
-
Five-year results from chemonucleolysis with chymopapain or collagenase: a prospective randomized study.Spine (Phila Pa 1976). 2001 Sep 1;26(17):1835-41. doi: 10.1097/00007632-200109010-00002. Spine (Phila Pa 1976). 2001. PMID: 11568690
-
Tanezumab: a selective humanized mAb for chronic lower back pain.Ther Clin Risk Manag. 2018 Feb 21;14:361-367. doi: 10.2147/TCRM.S144125. eCollection 2018. Ther Clin Risk Manag. 2018. PMID: 29503555 Free PMC article. Review.
Cited by
-
Fatigue severity and fatigue sensitivity: relations to anxiety, depression, pain catastrophizing, and pain severity among adults with severe fatigue and chronic low back pain.Behav Med. 2022 Jul-Sep;48(3):181-189. doi: 10.1080/08964289.2020.1796572. Epub 2020 Jul 23. Behav Med. 2022. PMID: 32703094 Free PMC article.
-
Acupotomy versus Manual Acupuncture for the Treatment of Back and/or Leg Pain in Patients with Lumbar Disc Herniation: A Multicenter, Randomized, Controlled, Assessor-Blinded Clinical Trial.J Pain Res. 2020 Apr 1;13:677-687. doi: 10.2147/JPR.S234761. eCollection 2020. J Pain Res. 2020. PMID: 32280270 Free PMC article.
-
The Clinical Efficacy of Platelet-Rich Plasma Injection Therapy versus Different Control Groups for Chronic Low Back Pain: A Network Meta-Analysis of Randomized Controlled Trials.J Pain Res. 2024 Mar 14;17:1077-1089. doi: 10.2147/JPR.S444189. eCollection 2024. J Pain Res. 2024. PMID: 38505505 Free PMC article.
-
Two Surgeries Do Not Always Make a Right: Spinal Cord Stimulation for Failed Back Surgery Syndrome.Yale J Biol Med. 2018 Sep 21;91(3):323-331. eCollection 2018 Sep. Yale J Biol Med. 2018. PMID: 30258319 Free PMC article. Review.
-
Mesenchymal Stem Cell-Derived Exosomes and Intervertebral Disc Regeneration: Review.Int J Mol Sci. 2022 Jun 30;23(13):7306. doi: 10.3390/ijms23137306. Int J Mol Sci. 2022. PMID: 35806304 Free PMC article. Review.
References
-
- From the Centers for Disease Control and Prevention Prevalence of disabilities and associated health conditions among adults – United States. JAMA. 2001;285(12):1571–1572. - PubMed
-
- Simon J, McAuliffe M, Shamim F, Vuong N, Tahaei A. Discogenic low back pain. Phys Med Rehabil Clin N Am. 2014;25(2):305–317. - PubMed
-
- Kepler CK, Ponnappan RK, Tannoury CA, Risbud MV, Anderson DG. The molecular basis of intervertebral disc degeneration. Spine J. 2013;13(3):318–330. - PubMed
-
- Raj PP. Intervertebral disc: anatomy-physiology-pathophysiology-treatment. Pain Pract. 2008;8(1):18–44. - PubMed
-
- Roberts S, Urban S, Jill PG. Encyclopedia of Occupational Health and Safety; 2012. [Accessed April 21, 2017]. Intervertebral discs. Available from: http://www.iloencyclopaedia.org/part-i-47946/musculoskeletal-system/17-6....
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous